Share This Page
Drug Price Trends for ATAZANAVIR SULFATE
✉ Email this page to a colleague
Average Pharmacy Cost for ATAZANAVIR SULFATE
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ATAZANAVIR SULFATE 300 MG CAP | 69238-1138-03 | 3.47230 | EACH | 2025-03-19 |
| ATAZANAVIR SULFATE 300 MG CAP | 31722-0655-30 | 3.47230 | EACH | 2025-03-19 |
| ATAZANAVIR SULFATE 300 MG CAP | 00093-5528-56 | 3.47230 | EACH | 2025-03-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Atazanavir Sulfate
Introduction to Atazanavir Sulfate
Atazanavir sulfate is a protease inhibitor used in the treatment of HIV infection, often administered in combination with other antiretroviral agents to prevent the development of drug-resistant viruses. Here, we will delve into the market analysis and price projections for this crucial medication.
Market Size and Growth
The global atazanavir sulfate market has been experiencing steady growth, driven by the increasing prevalence of HIV and the need for effective antiretroviral therapies. As of 2018, the global market size was valued at a significant figure, and it is projected to expand at a notable Compound Annual Growth Rate (CAGR) from 2019 to 2025[4].
Market Competition
The market for atazanavir sulfate is characterized by competition among various pharmaceutical companies. The competition is analyzed both by company and by country, with key players operating in the USA, EU, Japan, and China. The market competition is intense, with companies vying for market share through innovative production technologies and strategic partnerships[4].
Production and Manufacturing
Atazanavir sulfate production involves complex manufacturing processes. In Brazil, for instance, the Oswaldo Cruz Foundation (Fiocruz) has been involved in a significant project to produce the drug domestically. This initiative, which began in 2013, aimed to train Brazilian professionals in the production technology provided by Bristol-Myers Squibb. By 2017, Brazil was producing atazanavir sulfate locally, significantly reducing the country's expenditure on importing the drug[3].
Price Analysis
The cost of atazanavir sulfate varies based on the dosage and the pharmacy. Here are some current price points:
- 150 mg oral capsule: Around $477 for a supply of 60 capsules, translating to approximately $7.94 per unit[2].
- 200 mg oral capsule: Around $811.58 for a supply of 60 capsules, which is about $13.53 per unit[2].
- 300 mg oral capsule: Around $315.31 for a supply of 30 capsules, which is approximately $10.51 per unit[2].
These prices are for cash-paying customers and do not reflect the costs with insurance plans.
Cost Effectiveness and Economic Impact
Studies have compared the cost effectiveness of atazanavir with other protease inhibitors like lopinavir/ritonavir. For example, one study found that the daily cost of atazanavir was $22.08, compared to $18.52 for lopinavir/ritonavir. Over a 10-year period, patients on lopinavir/ritonavir had lower total healthcare costs and better clinical outcomes, highlighting the economic benefits of choosing the more cost-effective regimen[5].
Domestic Production and Savings
In Brazil, the domestic production of atazanavir sulfate has led to significant cost savings. The country expected to save approximately R$385 million (around $185.3 million) over five years by producing the drug locally. This initiative also ensured that the drug was available at a price 5% lower than the current market price, benefiting a large number of HIV-infected patients[3].
Market Forecast
Looking ahead, the global and Chinese atazanavir sulfate market is expected to see continued growth. Here are some key projections:
- Capacity and Production: The global capacity and production of atazanavir sulfate are forecasted to increase from 2024 to 2029, driven by growing demand and advancements in manufacturing technology[4].
- Market Share: The market share of atazanavir sulfate is expected to remain significant, with key countries like the USA, EU, Japan, and China contributing substantially to the global market[4].
- Supply and Consumption: The supply and consumption of atazanavir sulfate are anticipated to rise, reflecting the increasing need for antiretroviral therapies worldwide[4].
Industry Chain and Economic Environment
The atazanavir sulfate market is influenced by various factors in the industry chain, including upstream raw materials, downstream industries, and macroeconomic conditions. The global and Chinese macroeconomic environments play a crucial role in shaping the market dynamics and growth prospects of atazanavir sulfate[4].
Challenges and Opportunities
The atazanavir sulfate market faces several challenges, including patent expirations, competition from generic versions, and regulatory hurdles. However, there are also opportunities for growth through strategic partnerships, technological innovations, and expanding into new markets[4].
Key Takeaways
- Market Growth: The global atazanavir sulfate market is expected to grow steadily, driven by increasing demand for antiretroviral therapies.
- Price Variability: The cost of atazanavir sulfate varies based on dosage and pharmacy, with significant savings potential through domestic production.
- Cost Effectiveness: Atazanavir sulfate is less cost-effective compared to some other protease inhibitors, but its local production can lead to substantial cost savings.
- Market Forecast: The market is projected to see increased capacity, production, and consumption from 2024 to 2029.
FAQs
What is atazanavir sulfate used for?
Atazanavir sulfate is used in the treatment of HIV infection, typically administered in combination with other antiretroviral agents to prevent drug-resistant viruses.
How much does atazanavir sulfate cost?
The cost varies by dosage: around $477 for 60 capsules of 150 mg, $811.58 for 60 capsules of 200 mg, and $315.31 for 30 capsules of 300 mg.
What are the benefits of domestic production of atazanavir sulfate?
Domestic production can lead to significant cost savings, as seen in Brazil where local production saved approximately R$385 million over five years.
Is atazanavir sulfate cost-effective compared to other protease inhibitors?
Atazanavir sulfate is less cost-effective than some other protease inhibitors like lopinavir/ritonavir, but it remains a crucial treatment option due to its efficacy.
What are the market projections for atazanavir sulfate?
The global market is expected to grow, with increased capacity, production, and consumption forecasted from 2024 to 2029.
Sources
- Market Research Report Summary: Global Atazanavir Sulfate Market Growth 2024-2030 report.
- Drugs.com: Atazanavir Prices, Coupons, Copay Cards & Patient Assistance.
- Pharmaceutical Executive: All's Fair in Brazil's War on AIDS.
- Prof-Research: Atazanavir Sulfate Market Size, Share, Trend and Forecast to 2025.
- PubMed: Cost effectiveness of lopinavir/ritonavir compared with atazanavir in HIV-infected patients.
More… ↓
